NICE pauses final decision on ocrelizumab for primary progressive MS

Source MS Trust: NICE has announced that it is pausing the publication of final guidance for ocrelizumab for primary progressive multiple sclerosis.

The final decision was due to be published on the NICE website on 31 October and would have rejected ocrelizumab as an NHS treatment for primary progressive MS on the grounds of cost-effectiveness.

The MS Trust now understands that this final decision has been postponed(link is external) while further discussions take place between the drug company and NHS England. We welcome this move as it demonstrates a willingness on both sides to engage further in the debate around this drug which could have a substantial impact on the lives of people with primary progressive MS.  Read on.

Centre Christmas Lunch 


Date – Wednesday 12th December

Time – 12 for 12.30

Venue – Park Place Brasserie, Milton Park

Price – 3 courses £18, 2 courses £16 (including tip)


Leek and Potato Soup (V) (GF)

Salmon Gravadlax with a Beetroot and Horseradish Salad and Caper Dressing

Chicken Liver Pate with Festive Chutney

all served with Bread rolls

Main courses:

Roast Turkey Crown  served with pigs in blankets and stuffing (GF on request)

Butternut Squash Lasagne served with tomato and garlic bread (V)

Baked Lemon Butter Salmon En Papillote, baked salmon on a bed of vegetable mirepoix with lemon butter and white wine sauce (GF)

Steak, Guinness and Walnut Pie, slow cooked prime beef, marinated with guinness and braised with pickled walnuts.  Served in a herb crusted pastry tulip

All served with a selection of seasonal vegetables, roasted and new potatoes


Warm Belgium Chocolate Fudge Cake (V)

Christmas Pudding with Brandy Sauce (GF on request)

Normandy Apple Tart with fresh Cream (V)

Coffee and Mince Pies

Merry Christmas!

October 100 club winners

October 100 club winners:

1st Sue Doran

2nd Babs Copley

3rd Angie Duncan

Join our 100 club for a share of the 100 prize fund every month, speak to Sue or Reception for details, just £5 a month.

Milton Park Monthly Updates

Milton Park
An MEPC Asset
30th October 2018
Issue 002
This newsletter brings you the latest and greatest stories from around the park.
October has been a busy month, with November set to be even busier with the opening of Courtyard by Marriott on 12th November. Please contact Jordan Rowefor more information. Carry on reading to find our more!
Published on: 27/09/2018
Veronica wins prestigious award
Thank you for taking part in the Milton Park 2040 Vision Survey! We had nearly 1200 participants take part and the responses have been brilliant. They’ve given the team some good ideas and perceptions for the continuation of the 2040 Vision project.
November Mingle
The Mingle at Milton Park returns again. Join the Milton Park team for a Travel Special event. You will hear from award winning Travel Advisor, Veronica and John Birtwistle from First Group on The Future of Mobility. Don’t forget to mingle and of course, eat!
Published on: 27/09/2018
Wave Optics take space at 141 Park Drive East
Read Article
Milton Park Christmas Market 2018
2040 Vision open house drop-in session
News stories are regularly added so keep on visiting the news page at:
Milton Park Logo
MEPC Milton Park, Innovation Centre, 99 Park Drive, Oxford, Oxfordshire, OX14 4RY
T: 01235 865 555 E:
This email was distributed on behalf of MEPC Limited Registered Office: MEPC Ltd, Sixth Floor, 150 Cheapside, London, EC2V 6ET. Registered in England No. 5514581

Date for your diaries

Date for your diaries:

WEDS 12th DECEMBER, MS Centre Christmas Lunch at Park Place Brasserie, Milton Park, 12 for 12.30.  Further details will follow soon.

Novartis bets priority review voucher on its next big multiple sclerosis drug — eyes US, EU approvals in ’19

Source Endpoints News: One of Novartis’ top late-stage candidates for multiple sclerosis is now under review on both sides of the Atlantic.

Having stoked enthusiasm for siponimod through a solid Phase III data package, the Swiss drugmaker traded in a priority review voucher at the FDA for an expedited action date around March of next year. The EMA decision, meanwhile, will likely come in late 2019.

If Novartis appears upbeat, it’s for obvious reasons.  Read on. 

Former watchdog chief labels disabled benefits process a ‘hostile environment’

Source The Guardian: Andrew McDonald, who chaired Independent Parliamentary Standards Authority, says the system is ‘Kafka-esque’

A former top civil servant has criticised the disability benefits assessment system as a “hostile environment” after being told he was ineligible for support despite having Parkinson’s and terminal prostate cancer.

Andrew McDonald, 56, who ran the parliamentary body overseeing MPs expenses before retiring on health grounds, had his benefits stopped after assessors decided he was no longer ill enough to qualify for personal independence payment (PIP).  Read on.

Medical Cannabis To Be Available On Prescription ‘Within Weeks’

Source Huffington Post: Medical cannabis will be available on prescription in the UK within a month, according to The Telegraph.

The Home Office is expected to announce the “rescheduling” of cannabis-derived medicines in Parliament within a fortnight, lifting restrictions which mean that until now it has only been allowed in the most exceptional circumstances within a matter of weeks.

Under the new rules, those suffering chronic pain, severe epilepsy or nausea as a result of chemotherapy could be prescribed the drug by specialist doctors.

There are an estimated 28 million people living with chronic pain in the UK, including those suffering from conditions such as arthritis and multiple sclerosis (MS).

The MS Society said that 10,000 people suffering from that condition alone could benefit from the treatment.  Read on.

Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis

Source Neurology Advisor: Increased levels of physical activity may lead to decreased vascular risk profiles in patients with multiple sclerosis, according to a literature review published in Multiple Sclerosis and Related Disorders.

Researchers in this review searched for published articles in 5 major databases for studies involving physical activity, sedentary lifestyles, or exercise training and the impact these factors have on vascular comorbidities in patients with multiple sclerosis.  Read on.

Benefit errors trigger £5,000 refunds

Source BBC: Assessors wrongly calculated the income of thousands of people during the process that resulted in people moving from incapacity benefit and severe disability allowance onto ESA.

Tens of thousands of people on sickness benefits will receive backdated payments averaging £5,000 following government errors.

The Department for Work and Pensions (DWP) has revealed it is paying more than £1.5bn due to the mistakes.

Some people have already received payouts of more than £10,000.

The mistaken calculations were made when people were moved on to the main sickness benefit, the Employment and Support Allowance (ESA).

The errors were first revealed by BBC News in November, but the scale of the underpayments has now emerged.  Read on.